This Government Contract opportunity from Department Of Veterans Affairs was posted on June 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Molecular Pathology Testing – PD-L1 Biomarker Analysis

Closed

Federal

Submission Closed06/26/2026, 08:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

Federal

Reference Laboratory Testing Services

Network Contract Office 23 (36C263)

POSTED

DEADLINE

Therapeutic Apheresis Service Provider

Network Contract Office 23 (36C263)

POSTED

DEADLINE

GEM-X Single Cell 5’ Gene Expression Kits and Companion Reagents.

Solicitation # 75N98026Q01198

The National Institutes of Health intends to award a firm-fixed-price purchase order to 10x Genomics for GEM-X Single Cell 5 prime Gene Expression Kits and companion reagents. This procurement includes specific quantities of Universal 5 prime Gene Expression v3 Kits, Chromium GEM-X Single Cell 5 prime Chip Kits v3, and Dual Index Kit TT Set A Kits. These materials are required to analyze gene expression profiles for approximately 96 individuals to identify risk factors and therapeutic targets for cardiometabolic diseases. The government is pursuing a sole-source procurement under FAR 6.302-1 because 10x Genomics is the sole manufacturer of these proprietary products, which are essential for maintaining compatibility with existing research workflows and previously collected data. While this is not a request for competitive quotations, interested parties may submit capability statements to the NIH by 9:00 a.m. EDT on September 21, 2026. The government expects to make an award approximately five calendar days after the closing date.

National Institutes Of Health Olao

POSTED

DEADLINE

Q301--VISN 22 Semen & Vasectomy Test Kits

Solicitation # 36C26226Q1411_1

Solicitation 36C26226Q1411 is a request for a single-award, firm-fixed-price Blanket Purchase Agreement to provide a comprehensive one-stop shop for Semen Analysis and Post Vasectomy Semen Analysis testing for the Department of Veterans Affairs VISN 22 healthcare centers. The contractor is responsible for providing FDA registered prepackaged mail-in kits for home self-collection, managing all logistics, and performing laboratory testing. The requirement includes the provision of all necessary supplies, such as temperature-controlled packaging with seasonal gel packs and non-toxic preservatives, ensuring specimens remain stable for at least 48 hours. The contract structure consists of a base year and four optional years, with annual estimated quantities of 1,104 Full Semen Analysis kits and 636 Post Vasectomy Semen Analysis kits. Notably, the contractor must provide up to two repeat PVSA tests at no additional cost. This procurement is a total small business set-aside under NAICS 62151//621511. The performing laboratory must maintain CLIA certification, although the previous requirement for CAP accreditation has been removed via amendment. Compliance with HIPAA, OSHA bloodborne pathogen standards, and DOT hazardous materials regulations for infectious substances is mandatory. Award will be granted to the responsible offeror who is technically acceptable and provides the lowest price. Following several amendments, the final response deadline for offers is September 18, 2026, at 07:00 Pacific Time.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Q301--VISN 22 Semen & Vasectomy Test Kits

Solicitation # 36C26226Q1411_

The Department of Veterans Affairs, through the Network Contract Office 22, is soliciting bids for the procurement of Semen and Vasectomy Test Kits under solicitation number 36C26226Q1411. This combined contract opportunity is designated as a total set-aside for small businesses and falls under NAICS code 621511. The response deadline for this requirement is September 8, 2026, at 2:00 PM. Interested parties should direct inquiries to the primary point of contact, Contract Specialist Marcos Diaz, regarding this procurement for the Gilbert, Arizona office.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Blood Draw, Drug, and Alcohol Testing Services

Solicitation # 200996

The City of Chattanooga Business Unit in Tennessee is seeking a provider for Blood Draw, Drug, and Alcohol Testing Services to support the Chattanooga Police Department. This solicitation, identified by number 200996, is for a four year agreement. The response deadline for this opportunity is September 16, 2026. Interested parties should coordinate with the buyer, Ariana Lynn Pazouki, regarding the submission of proposals for these medical testing services within the state of Tennessee.

City of Chattanooga Business Unit

POSTED

DEADLINE

Clinical Blood Processing and Diagnostic Testing

Defense Health Agency

POSTED

DEADLINE

Supply of BreathID Diagnostic Instrument

POSTED

DEADLINE

Anatomical Dissection and Serology Testing

POSTED

DEADLINE

Oncotype IQ Genomic Tests

Solicitation # 12468583-0001

The Defense Health Agency is conducting market research to identify qualified sources capable of providing the Oncotype IQ portfolio of genomic tests for the Walter Reed National Military Medical Center in Bethesda, Maryland. This Sources Sought notice is for planning purposes and is not a formal solicitation. The government is seeking capability statements from all interested parties, including large and small businesses under NAICS code 621511, to determine if there are sufficient qualified vendors to perform the work. Selected contractors will be responsible for providing all labor, materials, equipment, and transportation necessary for the genomic tests, with a requirement to deliver products within 10 days of receiving an order. Interested respondents must submit a detailed capability statement, including company identification and evidence of prior similar experience, via email to the designated points of contact by September 24, 2026. All correspondence must be handled through email, as phone calls and meetings are not permitted.

Defense Health Agency

POSTED

DEADLINE

BPA for Medical Laboratory Testing Services at 18th Medical Group - Kadena Air Base, Japan

Solicitation # HT941026Q2050

Solicitation HT941026Q2050 is a request for a five-year Blanket Purchase Agreement to provide medical reference laboratory testing services for the 18th Medical Group at Kadena Air Base, Japan. The scope of work includes providing all management, labor, and equipment for specific tests, including fungal culture and identification, TSPOT-TB testing, and antifungal drug susceptibility tests. The contractor must maintain current accreditation with the College of American Pathologists. While the original period of performance was slated for October 1, 2026, through September 30, 2031, subsequent amendments updated the period of performance to December 1, 2026, through November 30, 2031. The procurement is unrestricted and open for full and open competition under NAICS code 621511, although Amendment 5 removed the total small business set-aside clause. Award will be determined on a past performance price tradeoff basis, where past performance is considered more important than price. Technical capability will be rated as acceptable or unacceptable, and the government may accept a higher-priced quote if the quoter's past performance outweighs the price difference. Quotes must be submitted electronically to the Defense Health Agency Healthcare Contracting Division West by October 26, 2026.

Defense Health Agency Hcd West

POSTED

DEADLINE

Clinical Blood Processing

Solicitation # HT942626QE058

The Defense Health Agency is soliciting a Blanket Purchase Agreement for clinical blood processing laboratory support services to benefit the Walter Reed Army Institute of Research, specifically the Center for Military Psychiatry and Neurosciences Research. The contractor will be responsible for picking up study participant blood samples from facilities in Silver Spring, Maryland, processing them at a certified off-site laboratory, and providing electronic results via a secure digital portal within 72 hours of pick-up. The scope includes a variety of tests such as Complete Metabolic Panels, Complete Blood Counts, and various Vitamin D and Calcium tests, with an estimated annual maximum of 2,950 units per item. The BPA features a five-year ordering period from September 30, 2026, to September 29, 2031, with a collective maximum value not to exceed 349,000 dollars. Award will be determined using the Lowest Price Technically Acceptable methodology, evaluating offerors based on their past performance and technical capabilities. Required credentials include CAP accreditation, CLIA certification, a medical laboratory permit, and the medical licenses and CVs of laboratory medical directors. The contract is set aside for small businesses, including HUBZone, SDVOSB, and EDWOSB entities. Performance will be monitored through a Quality Assurance Surveillance Plan, and the contractor must submit a comprehensive Quality Control Plan within 15 days of award. Payments will be processed via credit card for orders under 25,000 dollars and through the Wide Area Workflow system for orders exceeding that amount.

Defense Health Agency

POSTED

2 days ago

DEADLINE

in 12 days

AI Contract Overview

The contract involves performing PD-L1 immunohistochemistry testing on tissue specimens, which is critical for informing cancer immunotherapy treatment decisions. This subcontract, titled "Molecular Pathology Testing – PD-L1 Biomarker Analysis," was posted on June 15, 2026, with a response deadline of June 26, 2026. The work is to be performed primarily in Phoenix, with the postal code 85012, under the oversight of the Department of Veterans Affairs through its 262-NETWORK Contract Office 22. This contract falls under the NAICS code 621511, indicating it relates to medical laboratories. No specific set-aside provisions or designated organization types are mentioned. The contract emphasizes the molecular pathology testing required to support clinical care, particularly for veterans, by helping guide personalized cancer treatment strategies using biomarker analysis.